Xeris Biopharma Holdings (XERS) EBIT Margin (2020 - 2026)
Xeris Biopharma Holdings' EBIT Margin was 5.62% in Q2 2026, down 0.65 percentage points from 6.27% a year earlier and down 3.91 percentage points from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) EBIT Margin (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Xeris Biopharma Holdings' EBIT Margin was 10.91% through Jun 30, 2026, up 14.90 percentage points year-over-year; for FY2025, it was 8.53%, up 25.10 percentage points from FY2024.
- EBIT Margin has now increased for five consecutive years, with a five-year change of +417.37 percentage points (FY2020 to FY2025).
- In earlier years, EBIT Margin was -16.57% in FY2024 (+10.28 pp), -26.85% in FY2023 (+47.47 pp), -74.32% in FY2022 (+157.89 pp) and -232.22% in FY2021 (+176.62 pp).
- The Q2 2026 figure marks the lowest quarterly EBIT Margin since Q1 2025.
- Compared with a year earlier, EBIT Margin was higher in six of the last eight quarters, with an average year-over-year change of +16.02 percentage points.
- The best year-over-year quarter for EBIT Margin over five years was Q2 2022 (a gain of 214.80 percentage points); the worst was Q3 2021 (a drop of 74.08 percentage points).
- Per Business Quant data, XERS's EBIT Margin in the three quarters before Q2 2026 was 9.52% (Q1 2026), 19.55% (Q4 2025) and 9.05% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Xeris Biopharma Holdings | 1.71 Bn | 1.27 Bn | 79.59 Mn | 5.62% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.62% |
| Mar 31, 2026 | 9.52% |
| Dec 31, 2025 | 19.55% |
| Sep 30, 2025 | 9.05% |
| Jun 30, 2025 | 6.27% |
| Mar 31, 2025 | -5.14% |
| Dec 31, 2024 | 2.79% |
| Sep 30, 2024 | -23.76% |
| Jun 30, 2024 | -17.03% |
| Mar 31, 2024 | -35.05% |
| Dec 31, 2023 | -22.17% |
| Sep 30, 2023 | -10.17% |
| Jun 30, 2023 | -42.04% |
| Mar 31, 2023 | -40.00% |
| Dec 31, 2022 | -45.77% |
| Sep 30, 2022 | -63.18% |
| Jun 30, 2022 | -74.75% |
| Mar 31, 2022 | -131.72% |
| Dec 31, 2021 | -225.26% |
| Sep 30, 2021 | -220.24% |
API Access
Xeris Biopharma Holdings EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();